Kiyama Ryoiti
Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), 1-11 Higashi, Tsukuba 305-8566, Ibaraki, Japan.
Microarrays (Basel). 2017 Jan 30;6(1):4. doi: 10.3390/microarrays6010004.
The application of DNA microarray assay (DMA) has entered a new era owing to recent innovations in omics technologies. This review summarizes recent applications of DMA-based gene expression profiling by focusing on the screening and characterizationof traditional Chinese medicine. First, herbs, mushrooms, and dietary plants analyzed by DMA along with their effective components and their biological/physiological effects are summarized and discussed by examining their comprehensive list and a list of representative effective chemicals. Second, the mechanisms of action of traditional Chinese medicine are summarized by examining the genes and pathways responsible for the action, the cell functions involved in the action, and the activities found by DMA (silent estrogens). Third, applications of DMA for traditional Chinese medicine are discussed by examining reported examples and new protocols for its use in quality control. Further innovations in the signaling pathway based evaluation of beneficial effects and the assessment of potential risks of traditional Chinese medicine are expected, just as are observed in other closely related fields, such as the therapeutic, environmental, nutritional, and pharmacological fields.
由于组学技术的最新创新,DNA微阵列分析(DMA)的应用已进入一个新时代。本综述通过聚焦于中药的筛选和表征,总结了基于DMA的基因表达谱分析的近期应用。首先,通过研究其综合列表和代表性有效化学成分列表,总结并讨论了经DMA分析的草药、蘑菇和食用植物及其有效成分和生物/生理效应。其次,通过研究负责该作用的基因和途径、该作用涉及的细胞功能以及DMA发现的活性(沉默雌激素),总结了中药的作用机制。第三,通过研究已报道的实例和其在质量控制中的新应用方案,讨论了DMA在中药中的应用。正如在其他密切相关领域,如治疗、环境、营养和药理学领域所观察到的那样,预计在基于信号通路的中药有益作用评估和潜在风险评估方面将有进一步创新。